Kawashima procedure

From WikiMD's WELLNESSPEDIA

Kawashima procedure is a surgical procedure used in the treatment of certain congenital heart defects, particularly those involving single-ventricle physiology. Named after the Japanese surgeon who first described it, Dr. Kawashima, this procedure is often used as a palliative treatment for patients with complex heart defects who are not candidates for a more definitive repair.

Indications[edit]

The Kawashima procedure is typically indicated for patients with single-ventricle physiology who also have anomalous pulmonary venous connection to the superior vena cava (SVC) or the right atrium. This includes conditions such as heterotaxy syndrome, asplenia syndrome, and polysplenia syndrome.

Procedure[edit]

The Kawashima procedure involves the redirection of blood flow from the SVC to the pulmonary arteries, bypassing the heart. This is achieved by disconnecting the SVC from the heart and connecting it to the pulmonary arteries. The goal of the procedure is to improve oxygenation of the blood by allowing deoxygenated blood from the upper body to flow directly to the lungs, bypassing the single functioning ventricle.

Outcomes[edit]

While the Kawashima procedure is a palliative treatment and not a cure, it can significantly improve the quality of life for patients with complex heart defects. It can help to alleviate symptoms such as cyanosis (bluish discoloration of the skin due to low oxygen levels), fatigue, and shortness of breath. However, long-term outcomes can vary widely depending on the specific heart defect and the overall health of the patient.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.